Package 69452-160-13

Brand: deferasirox

Generic: deferasirox
NDC Package

Package Facts

Identity

Package NDC 69452-160-13
Digits Only 6945216013
Product NDC 69452-160
Product ID 69452-160_2f9b625f-3835-4481-e063-6394a90a4bf3
Description

30 TABLET, FOR SUSPENSION in 1 BOTTLE (69452-160-13)

Marketing

Marketing Status
Marketed Since 2018-09-28
Brand deferasirox
Generic deferasirox
Sample Package No

Linked Drug Pages (1)

Deferasirox ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2f9b625f-3835-4481-e063-6394a90a4bf3", "openfda": {"nui": ["N0000000144", "N0000175522", "N0000185506", "N0000187062", "N0000182138"], "upc": ["0369452161135"], "unii": ["V8G4MOF2V9"], "rxcui": ["597768", "597770", "597772"], "spl_set_id": ["dc690f20-533e-490e-b13d-143382e02351"], "pharm_class_epc": ["Iron Chelator [EPC]"], "pharm_class_moa": ["Iron Chelating Activity [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]"], "manufacturer_name": ["Bionpharma Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FOR SUSPENSION in 1 BOTTLE (69452-160-13)", "package_ndc": "69452-160-13", "marketing_start_date": "20180928"}], "brand_name": "Deferasirox", "product_id": "69452-160_2f9b625f-3835-4481-e063-6394a90a4bf3", "dosage_form": "TABLET, FOR SUSPENSION", "pharm_class": ["Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Iron Chelating Activity [MoA]", "Iron Chelator [EPC]"], "product_ndc": "69452-160", "generic_name": "deferasirox", "labeler_name": "Bionpharma Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Deferasirox", "active_ingredients": [{"name": "DEFERASIROX", "strength": "250 mg/1"}], "application_number": "ANDA210920", "marketing_category": "ANDA", "marketing_start_date": "20180928", "listing_expiration_date": "20261231"}